This is a professionally developed, interactive and highly engaging Good Clinical Practice (GCP) course, incorporating ICH E6 R2 (2017), which is suitable for anyone carrying out or involved in clinical research. This new GCP course, updated for 2020, has improved knowledge checks and interaction to create a more engaging experience for our users.
This course develops knowledge and understanding of what GCP is and why it is necessary, considering the historical background behind the guidelines. Key legislation linked to GCP is also examined as are the roles and responsibilities of the key stakeholders in a Clinical Trial in relation to GCP compliance. The implications of GCP compliance such as ethical considerations, patient safety, Informed Consent, Investigational Product (IP) and key documentation are explained, with opportunities for the learner to consider practical issues relating to these topics.
This course meets the required standards for ICH GCP Investigator site personnel training identified by Transcelerate Biopharma inc. and will provide individuals with official certification in GCP that is widely accepted by all Sponsors and CROs.
- Understand what GCP is, why it is necessary and its practical implications.
- Examine key legislation surrounding GCP.
- Learn the responsibilities of the key stakeholders in a Clinical Trial and how these relate to GCP.
- Develop extensive knowledge and understanding of GCP to ensure compliance.
- Understand the importance of key documents relating to Clinical Trials including the protocol, Investigator Brochure and Essential Documents.
- Learn how to assess GCP compliance and understand how to effectively tackle under-performance.
All prices include VAT at 20%
If you have a discount code this can be entered on the next page after clicking “Take This Course”
This is the new updated course of GCP for 2020 to remain current and has improved knowledge checks and interaction to create a more engaging experience for our users.
You will also gain free access to our online course – “Managing Clinical Trials During COVID-19“